Home » Lupin Resolves US FDA’s Concerns on India Unit
Lupin Resolves US FDA’s Concerns on India Unit
Pharma company Lupin Ltd said it has addressed all concerns related to its
manufacturing facility at Mandideep in Madhya Pradesh raised by the US health regulator Food and Drug Administration (FDA).
Business Standard
Business Standard
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May